Smith, M. A., Reynolds, P., Kang, M. H., Kolb, E. A., Gorlick, R., Carol, C. H., . . . Houghton, P. J. (2014). Synergistic Activity of PARP Inhibition by Talazoparib (BMN 673) with Temozolomide in Pediatric Cancer Models in the Pediatric Preclinical Testing Program. Clin Cancer Res.
استشهاد بنمط شيكاغوSmith, Malcolm A., et al. "Synergistic Activity of PARP Inhibition By Talazoparib (BMN 673) With Temozolomide in Pediatric Cancer Models in the Pediatric Preclinical Testing Program." Clin Cancer Res 2014.
MLA استشهادSmith, Malcolm A., et al. "Synergistic Activity of PARP Inhibition By Talazoparib (BMN 673) With Temozolomide in Pediatric Cancer Models in the Pediatric Preclinical Testing Program." Clin Cancer Res 2014.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.